Company profile
Oncternal Therapeutics, Inc. Insider Trading
ONCTEvery SEC Form 4 insider trading filing for Oncternal Therapeutics, Inc. (ONCT) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Sector
- Pharmaceutical Preparations
- CIK
- 0001260990
- Filings
- 46
- Insiders
- 15
- Last filing
- 2024-06-20
Activity summary
No insider transactions in the last 30 days. The most recent was on June 20, 2024, when Michael G Carter bought 2,200 shares. 46 filings from 15 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q2 23 to Q2 24. Oncternal Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $77K.
No insider activity recorded for ONCT in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 20, 2024 | Michael G Carter | ONCT | Award | 2,200 | — | — |
| Jun 20, 2024 | Jill DeSimone | ONCT | Award | 2,200 | — | — |
| Jun 20, 2024 | David F Hale | ONCT | Award | 3,300 | — | — |
| Jun 20, 2024 | Daniel L Kisner | ONCT | Award | 2,200 | — | — |
| Jun 20, 2024 | William R Larue | ONCT | Award | 2,200 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ONCT" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.